Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.22 USD | -3.82% | +1.40% | +49.17% |
05-02 | Agios Pharmaceuticals Shares Rise After Reporting Smaller Q1 Loss | MT |
05-02 | Transcript : Agios Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.17% | 1.89B | |
+9.15% | 106B | |
-1.08% | 104B | |
+5.79% | 23.25B | |
-11.55% | 22.5B | |
-7.01% | 18.7B | |
-37.08% | 17.95B | |
-9.91% | 16.99B | |
+7.55% | 14.26B | |
+40.04% | 12.76B |
- Stock Market
- Equities
- AGIO Stock
- News Agios Pharmaceuticals, Inc.
- JPMorgan Chase Adjusts Price Target on Agios Pharmaceuticals to $33 From $48, Maintains Neutral Rating